Another option is to use compounds that can form nontoxic complexes with Cu (II), preventing its accumulation in senile plaques and increasing its bioavailability
97 PonkaP
Harvey I, Boudreau A, Stephens JM
doi: 10.1016/j.abb.2017.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar] 119.Zhong M, Kawaguchi R, Costabile B, Tang Y, Hu J, Cheng G, et al
The aging population and growing prevalence of conditions like hypertension and atherosclerosis create demand for options beyond conventional treatments
Earlier this year, the FDA formally removed 12 peptides from its Category 2 "do not compound" list, restoring a path to physician-prescribed, pharmacy-compounded access for therapies millions of patients already rely on